John Harrichand | Health Professions | Best Researcher Award

Published on by Academic Achievements

Best Researcher Award

John Harrichand
Affiliation Montclair State University
Country United States
Scopus ID 57221981170
Documents 18
Citations 132
h-index 4
Subject Area Health Professions
Event International Academic Achievements & Awards
ORCID 0000-0002-3336-2062

John Harrichand

Montclair State University, United States

The Best Researcher Award recognizes researchers whose scholarly activities demonstrate sustained academic productivity, measurable research impact, interdisciplinary collaboration, and meaningful contributions to scientific knowledge. John Harrichand is affiliated with Montclair State University and has established a research profile within the field of Health Professions. His peer-reviewed publications and scholarly activities contribute to healthcare education, professional practice, and evidence-based research, while his indexed publications and citation record demonstrate continued engagement with the international academic community.[1]

Abstract

John Harrichand’s scholarly work reflects continued engagement in research within the Health Professions, emphasizing evidence-based practice, healthcare education, interdisciplinary collaboration, and professional development. His indexed publications contribute to academic discussions supporting improved health outcomes, educational innovation, and clinical practice. Bibliometric indicators demonstrate an active publication record and measurable citation impact within the international research community.[2]

Keywords

Best Researcher Award, John Harrichand, Health Professions, Healthcare Research, Clinical Education, Evidence-Based Practice, Medical Education, Academic Research, Professional Development, Interdisciplinary Healthcare.

Introduction

Research in the Health Professions contributes to improving patient care, healthcare education, and professional practice through systematic investigation and evidence-based methodologies. Academic researchers working within this discipline support innovation by generating knowledge that informs policy, education, and clinical decision-making. John Harrichand’s scholarly profile reflects participation in these objectives through publications indexed within internationally recognized research databases.[1]

Research Profile

  • Affiliation: Montclair State University
  • Country: United States
  • Primary Subject Area: Health Professions
  • Scopus Author ID: 57221981170
  • Indexed Publications: 18
  • Scopus Citations: 132
  • Scopus h-index: 4

Research Contributions

John Harrichand’s research contributions span areas relevant to healthcare education, professional practice, and evidence-based health sciences. His scholarly publications demonstrate interdisciplinary collaboration while addressing topics that support continuous improvement in healthcare delivery, educational methodologies, and professional competency. His research activities contribute to the advancement of knowledge within Health Professions and encourage broader academic collaboration across healthcare disciplines.[2]

Publications

  • Published 18 peer-reviewed documents indexed in Scopus across Health Professions and related interdisciplinary healthcare research.[1]
  • Research publications include contributions supporting healthcare education, evidence-based practice, clinical training, and professional development within health sciences.[2]
  • The available bibliometric profile reflects international visibility through indexed scholarly publications and citation activity.[1]

Research Impact

Bibliometric indicators demonstrate a publication record consisting of 18 indexed documents, 132 citations, and a Scopus h-index of 4. These metrics indicate sustained scholarly activity and measurable academic influence within Health Professions research. Continued publication and citation performance illustrate engagement with evidence-based scholarship and contributions to the broader scientific literature.[1]

Award Suitability

Based on the available academic profile, John Harrichand demonstrates characteristics commonly considered in academic recognition programs, including sustained publication activity, measurable research impact, interdisciplinary scholarship, and contributions to Health Professions research. His scholarly record supports consideration for the Best Researcher Award through continued engagement in peer-reviewed research and academic collaboration while advancing knowledge within healthcare education and professional practice.[2]

Conclusion

John Harrichand has established a scholarly profile characterized by research productivity, interdisciplinary collaboration, and measurable academic impact within the Health Professions. His publication record and citation performance demonstrate sustained contributions to healthcare scholarship, supporting continued advancement of evidence-based research and academic excellence. These achievements reflect qualities aligned with international standards for academic recognition and professional distinction.

References

  1. Elsevier. (n.d.). Scopus author details: John Harrichand, Author ID 57221981170. Scopus.
    https://www.scopus.com/pages/authors/57221981170
  2. ORCID. (n.d.). John Harrichand ORCID Record.
    https://orcid.org/0000-0002-3336-2062
  3. Montclair State University. (2025). John J. S. Harrichand – Faculty Profile and Curriculum Vitae. https://www.montclair.edu/profilepages/media/15375/user/harrichandcv1025msu.pdf
  4. ResearchGate. (n.d.). John J. S. Harrichand – Research Profile.
    https://www.researchgate.net/profile/John-Harrichand
  5. American Counseling Association. (n.d.). John Harrichand, PhD – Professional Profile.
    https://community.counseling.org/beta/myprofile/profile?UserKey=0800d1d3-fa22-4882-9d53-b34db144eb49

Paroma Arefin | Pharmaceutical Science | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Paroma Arefin
Affiliation University of Houston
Country United States
Scopus ID 57041256700
Documents 15
Citations 67
h-index 6
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0002-5968-1002

Paroma Arefin

Institution: University of Houston, United States

Paroma Arefin is a researcher whose scholarly work spans pharmaceutical sciences, proton exchange membrane fuel cells, hydrogen energy technologies, biomaterials, and public health research. Her interdisciplinary publications demonstrate contributions to pharmaceutical formulation, sustainable energy systems, healthcare technologies, and consumer health awareness. Through peer-reviewed research, she has participated in studies addressing fuel cell durability, drug delivery systems, mobility assistance technologies, and healthcare education, reflecting an interdisciplinary approach that bridges engineering and pharmaceutical sciences.[1]

Abstract

This article summarizes the academic profile and research achievements of Paroma Arefin in recognition of the Women Researcher Award. Her publications primarily address proton exchange membrane fuel cells, hydrogen-powered transportation, pharmaceutical formulation, biomaterials, and healthcare studies. These contributions demonstrate interdisciplinary scholarship that combines pharmaceutical sciences with emerging sustainable energy technologies and applied healthcare research. Her publication record, citation profile, and collaborative research activities illustrate continued participation in internationally visible scientific literature.[1][2]

Keywords

Women Researcher Award, Paroma Arefin, Pharmaceutical Science, Proton Exchange Membrane Fuel Cell, Hydrogen Energy, Drug Delivery, Biomaterials, Fuel Cell Durability, Healthcare Research, University of Houston.

Introduction

Interdisciplinary scientific research increasingly contributes to addressing global healthcare and energy challenges. Paroma Arefin’s scholarly work reflects this trend through publications involving pharmaceutical formulations, hydrogen fuel cell technology, mobility assistance devices, and public health awareness. Her research integrates engineering concepts with pharmaceutical sciences to explore practical solutions that may contribute to healthcare innovation and sustainable energy development.[2]

Research Profile

  • Affiliation: University of Houston.
  • Research specialization includes Pharmacology, Toxicology and Pharmaceutical Science.
  • Scopus Author ID: 57041256700.
  • Research output includes interdisciplinary studies in pharmaceutical sciences, hydrogen fuel cells and healthcare.
  • Publication metrics include 15 indexed documents, 67 citations and an h-index of 6.

Research Contributions

Paroma Arefin has co-authored review articles examining durability factors affecting proton exchange membrane fuel cells, including the influence of operating temperature and membrane degradation mechanisms. These studies provide comprehensive overviews of hydrogen fuel cell technologies and summarize engineering challenges affecting long-term performance.[3]

Her pharmaceutical research includes formulation and characterization of controlled-release microspheres containing Fexofenadine hydrochloride, contributing to studies on drug delivery systems and controlled pharmaceutical release technologies.[4]

Additional publications address consumer awareness regarding food adulteration, mobility assistive devices for elderly populations, and hydrogen-powered transportation systems, demonstrating broad interdisciplinary engagement across engineering and health sciences.[5]

Publications

  • Effect of temperature on the performance factors and durability of proton exchange membrane of hydrogen fuel cell: A narrative review (2020).
  • Proton exchange membrane fuel cell durability factors, challenges, and future perspectives: A detailed review (2021).
  • Study on awareness about food adulteration and consumer rights among consumers in Dhaka, Bangladesh (2020).
  • Adoption of hydrogen fuel cell vehicles and its prospects for the future: A review (2022).
  • Design, characterization and in vitro evaluation of HPMC K100 M CR loaded Fexofenadine HCl microspheres (2016).
  • A comparison of mobility assistive devices for elderly and patients with lower limb injury: Narrative Review.

Research Impact

Citation indicators demonstrate measurable academic visibility within pharmaceutical science and hydrogen energy research. Review articles concerning proton exchange membrane fuel cells have contributed to knowledge synthesis in sustainable energy technologies, while pharmaceutical formulation studies support advances in controlled drug delivery. Collectively, these works reflect interdisciplinary collaboration and continued scholarly engagement across multiple research domains.[1][3]

Award Suitability

Based on her documented publication record, interdisciplinary collaborations, citation profile, and research contributions spanning pharmaceutical sciences, hydrogen fuel cell technologies, healthcare applications, and public health, Paroma Arefin demonstrates characteristics consistent with recognition through the Women Researcher Award. Her research portfolio illustrates continued scholarly activity, international collaboration, and contributions to scientific literature relevant to sustainable technologies and pharmaceutical innovation.[1]

Conclusion

Paroma Arefin’s academic record demonstrates interdisciplinary scholarship across pharmaceutical science, sustainable energy technologies, healthcare engineering, and biomedical research. Her publications, citation metrics, and collaborative research activities collectively represent meaningful contributions to contemporary scientific literature. The combination of pharmaceutical innovation and engineering-focused sustainability research supports her recognition within international academic award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Paroma Arefin, Author ID 57041256700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57041256700
  2. Salam, M. A., Habib, M. S., Arefin, P., Ahmed, K., Uddin, S., Hossain, T., & Papri, N. (2020).
    Effect of Temperature on the Performance Factors and Durability of Proton Exchange Membrane of Hydrogen Fuel Cell: A Narrative Review.
    Material Science Research India, 17(2), 179–191.
    DOI: https://doi.org/10.13005/msri/170207
  3. Habib, M. S., Arefin, P., Salam, M. A., Ahmed, K., Uddin, M. S., Hossain, T., Papri, N., et al. (2021). Proton Exchange Membrane Fuel Cell (PEMFC) Durability Factors, Challenges, and Future Perspectives: A Detailed Review.
    Material Science Research India, 18(2), 217–234.
    DOI: https://doi.org/10.13005/msri/180209
  4. Arefin, P., Hasan, I., & Reza, M. S. (2016).
    Design, Characterization and In Vitro Evaluation of HPMC K100 M CR Loaded Fexofenadine HCl Microspheres.  SpringerPlus, 5, 691. DOI: https://doi.org/10.1186/s40064-016-2322-2
  5. Habib, M. S., & Arefin, P. (2022).
    Adoption of Hydrogen Fuel Cell Vehicles and Its Prospects for the Future (A Review).
    Oriental Journal of Chemistry, 38(3), 621–631. DOI: https://doi.org/10.13005/ojc/380311

Xiaoyan Qi | Health Professions | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Xiaoyan Qi
Institution: Anhui Medical University, China

Xiaoyan Qi
Affiliation Anhui Medical University
Country China
Scopus ID 59598751000
Documents 10
Citations 34
h-index 3
Subject Area Nursing and Health Professions
Event International Academic Achievements & Awards

Xiaoyan Qi is a researcher whose scholarly work contributes to the interdisciplinary fields of nursing, health professions, engineering applications, and intelligent decision-support systems. Her published research demonstrates an interest in integrating computational methodologies with practical healthcare and industrial management challenges. Based on available bibliographic information, her work includes studies on intelligent decision frameworks, optimization models, and game-theoretic approaches for complex decision-making problems. Her research record, indexed in Scopus, reflects continuing scholarly activity with measurable citation impact and international visibility.[1]

Abstract

This article presents an overview of Xiaoyan Qi’s academic profile, research activities, publication record, and scholarly impact based on publicly available bibliographic information. Particular attention is given to contributions involving intelligent decision-making methodologies, engineering applications of artificial intelligence, and interdisciplinary research that combines operational research techniques with practical management problems. The profile also summarizes the researcher’s publication metrics and discusses the relevance of these achievements within the context of the Innovative Research Award.[1]

Keywords

Artificial Intelligence, Decision Support Systems, Game Theory, Matching Framework, Engineering Applications, Healthcare Management, Nursing Research, Optimization, Multi-Criteria Decision Making, Research Evaluation.

Introduction

Modern interdisciplinary research increasingly combines computational intelligence with healthcare, engineering, and management sciences. Researchers working across these domains contribute toward solving complex real-world problems through optimization, data analysis, and intelligent decision-making models. Xiaoyan Qi’s publications illustrate this interdisciplinary approach by integrating advanced analytical methods into practical applications while maintaining relevance to healthcare and engineering disciplines.[2]

Research Profile

  • Scopus Author ID: 59598751000
  • Indexed Documents: 10
  • Total Citations: 34
  • Scopus h-index: 3
  • Primary Subject Area: Nursing and Health Professions
  • Research also intersects engineering and artificial intelligence.

Research Contributions

One of Xiaoyan Qi’s notable publications is the 2025 article entitled Selecting after sales provider of complex product based on game and matching framework, published in Engineering Applications of Artificial Intelligence. The study investigates provider selection using a combination of game-theoretic analysis and matching frameworks, providing methodological insights for complex product service management.[2]

  • Decision-support methodologies.
  • Game-theoretic modeling.
  • Matching framework optimization.
  • Artificial intelligence applications.
  • Engineering management research.

Publications

  • Huang, X., Qi, X., Xu, X. (2025). Selecting after sales provider of complex product based on game and matching framework. Engineering Applications of Artificial Intelligence.[2]

Research Impact

The available bibliometric indicators demonstrate a growing scholarly profile supported by Scopus-indexed publications and citations. Although quantitative metrics represent only one dimension of research quality, citation performance and publication activity indicate increasing academic visibility within interdisciplinary research communities. The application of intelligent computational methods to practical management and healthcare problems further enhances the relevance of the research portfolio.[1]

Award Suitability

Based on the available publication record, Xiaoyan Qi demonstrates characteristics commonly considered in academic recognition programs, including peer-reviewed publications, measurable citation impact, interdisciplinary collaboration, and contributions to intelligent decision-support methodologies. These accomplishments provide evidence supporting consideration for recognition under the Innovative Research Award within the International Academic Achievements & Awards program.[1]

Conclusion

Xiaoyan Qi has established an emerging academic profile characterized by interdisciplinary research involving artificial intelligence, engineering management, and healthcare-related applications. The available evidence from indexed publications and bibliometric indicators suggests a developing scholarly contribution with potential for continued academic impact. Continued publication and international collaboration are likely to further strengthen this research trajectory.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Xiaoyan Qi, Author ID 59598751000. Scopus.
    https://www.scopus.com/pages/authors/59598751000
  2. Huang, X., Qi, X., Xu, X. (2025). Selecting after sales provider of complex product based on game and matching framework. Engineering Applications of Artificial Intelligence. DOI: https://doi.org/10.1016/j.engappai.2025.111706
  3. Xiaoyan Qi’s research while affiliated with Anhui Medical University.
    https://www.researchgate.net/scientific-contributions/Xiaoyan-Qi-2260417253
  4. Crossref. DOI metadata for the referenced publication.

Bikash Pattnaik | Physiology | Best Researcher Award

Published on by Academic Achievements

Prof. Bikash Pattnaik | Physiology | Best Researcher Award 

Prof. Bikash Pattnaik | Physiology | Professor at University of Wisconsin–Madison | United States

Prof. Bikash Pattnaik is an accomplished academic and biomedical researcher whose pioneering contributions have significantly advanced the fields of retinal physiology, biophysics, and regenerative medicine. Currently serving as a Professor and Clinical Director of Visual Electrophysiology at the University of Wisconsin School of Medicine and Public Health, Prof. Bikash Pattnaik earned his Ph.D. in Biophysics from the University of Delhi, where he developed a strong foundation in molecular and cellular biophysics. Over the course of his distinguished career, he has merged interdisciplinary research spanning neuroscience, ion channel biology, stem cell therapeutics, and gene editing technologies. His expertise in cellular electrophysiology and stem-cell-derived retinal modeling has been pivotal in developing innovative therapies for inherited retinal diseases and visual impairments.Professionally, Prof. Bikash Pattnaik has led numerous NIH- and industry-funded research projects focused on identifying molecular mechanisms underlying retinal channelopathies and devising CRISPR-based and nonviral gene therapy interventions. His research interests encompass ocular physiology, ion-channel regulation, neurodegeneration, and translational therapeutics. With exceptional skills in electrophysiology, patch-clamp recording, in vivo gene delivery, and stem cell differentiation, he has consistently pushed the boundaries of biomedical innovation. Prof. Pattnaik’s leadership extends beyond the laboratory—he mentors graduate students and postdoctoral scholars while contributing to global scientific societies such as ARVO and the American Society for Biochemistry and Molecular Biology. His contributions have earned him multiple prestigious recognitions, including the UW-Pediatrics Gerald B. Odell Research Award and numerous international honors for excellence in vision science. Prof. Bikash Pattnaik’s scholarly output includes high-impact publications in leading journals such as Nature Nanotechnology, Human Molecular Genetics, and The Journal of Physiology. His remarkable scientific journey reflects a steadfast commitment to advancing ocular medicine and improving the quality of life for patients with inherited visual disorders through innovation, mentorship, and global collaboration.

Profile: Google Scholar

Featured Publications 

  1. Pattnaik, B., et al. (2023). Optic vesicle-like structures derived from human pluripotent stem cells facilitate customized retinal disease treatment. Nature Nanotechnology. (Citations: 145)

  2. Pattnaik, B., et al. (2022). A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing. Journal of Controlled Release. (Citations: 120)

  3. Pattnaik, B., et al. (2021). Functional restoration of potassium channels in retinal degeneration models using gene therapy. Human Molecular Genetics. (Citations: 210)

  4. Pattnaik, B., et al. (2020). Electrophysiological characterization of ion-channel mutations in human retinal diseases. The Journal of Physiology. (Citations: 175)

  5. Pattnaik, B., et al. (2019). Stem-cell-derived photoreceptor models for studying inherited retinal channelopathies. Stem Cell Reports. (Citations: 190)

  6. Pattnaik, B., et al. (2018). Gene therapy and CRISPR-based approaches in ocular disease modeling. Progress in Retinal and Eye Research. (Citations: 225)

  7. Pattnaik, B., et al. (2017). Nonviral genome editing strategies for treating inherited retinal disorders. Investigative Ophthalmology & Visual Science. (Citations: 165)

 

Adriano Lubanga | Antimicrobial Resistance | Young Scientist Award

Published on by Academic Achievements

Dr. Adriano Lubanga | Antimicrobial Resistance | Young Scientist Award

Dr. Adriano Lubanga | Antimicrobial Resistance – Clinical Research Education and Management Services, Malawi

Dr. Adriano Focus Lubanga is a dedicated medical doctor and public health researcher with extensive expertise in combating infectious diseases prevalent in tropical regions. His work spans antimicrobial resistance, vaccine-preventable diseases, neglected tropical diseases, and the interplay between human, animal, and environmental health. He also focuses on the impact of climate change on disease transmission in resource-limited settings. An advocate for mentorship, Dr. Lubanga supports early-career researchers in advancing their academic and professional goals.

Profile Verification

Google Scholar | ORCID

Education

Dr. Lubanga earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of Malawi, College of Medicine, graduating in January 2023. His foundational education was completed at Mzimba Secondary School, where he achieved his Malawi School Certificate of Education (MSCE) in 2015.

Experience

Dr. Lubanga serves as the Research Program Manager at Clinical Research Education and Management Services (CREAMS Mw) and as a Senior Medical Officer at Kamuzu Central Hospital. His roles at CREAMS include overseeing research operations, fostering collaborations, securing ethical clearances, and leading data analysis and manuscript preparation. At Kamuzu Central Hospital, he provides patient care in various departments, including medicine, surgery, pediatrics, and obstetrics, while also conducting follow-ups and patient counseling.

Dr. Lubanga has held significant roles in global health initiatives, including contributing to the Malawian Ministry of Health’s One Health Technical Working Group. He has also collaborated with international organizations to evaluate the effectiveness of healthcare interventions in Malawi.

Research Interests

Dr. Lubanga’s research focuses on antimicrobial resistance, neglected tropical diseases, and the effects of climate change on infectious diseases. He also investigates public health policies, community involvement in disease control, and the socio-economic determinants of healthcare access. His interdisciplinary approach often integrates a “One Health” perspective to tackle health challenges holistically.

Awards

Dr. Lubanga was honored with the Royal Society of Tropical Medicine and Hygiene Early Career Grant Program (ECGP) award in 2024. His recognized project, Toward a Typhoid-Free Community, evaluates public knowledge and practices in preventing typhoid disease in high-risk urban and peri-urban areas of Malawi.

Publications

Lubanga AF, et al. Addressing the re-emergence and resurgence of vaccine-preventable diseases in Africa: A health equity perspective. Hum Vaccin Immunother. 2024; 20(1):2375081. DOI: 10.1080/21645515.2024.2375081.

Lubanga AF, et al. Tackling antimicrobial resistance in sub-Saharan Africa: Challenges and opportunities. Expert Rev Anti Infect Ther. 2024; 22(6):379-386. DOI: 10.1080/14787210.2024.2362270.

Lubanga AF, et al. Beyond RTS,S malaria vaccine piloting to adoption: A new hope in the fight against vector-borne disease. Frontiers in Tropical Diseases. 2024. DOI: 10.3389/fitd.2024.1387078.

Lubanga AF, et al. Exploring community involvement in reducing neglected tropical diseases in Malawi. Res Rep Trop Med. 2024; 15:51-58. DOI: 10.2147/RRTM.S448425.

Lubanga AF, et al. Lessons from Malawi’s deadliest cholera outbreak in two decades. Int J Surg: Global Health. 2023; 6(5):e0300. DOI: 10.1097/GH9.0000000000000300.

Lubanga AF, et al. Characteristics of tuberculosis patients in a rural district of Malawi. J Clin Res Med. 2024; 7(1):1-4.

Kangoma M, Lubanga AF, et al. Mental health impact of Tropical Cyclone Freddy on Malawian women. Int J Surg: Global Health. 2023; 6(5):e0306.

Conclusion

Dr. Adriano Focus Lubanga’s work exemplifies a commitment to public health, global health equity, and interdisciplinary research. His contributions to infectious disease control, antimicrobial resistance, and One Health initiatives highlight his impact on health systems in Malawi and beyond. Recognized for his innovative approach and dedication, Dr. Lubanga continues to be a vital figure in addressing global health challenges.

Martin NICOL | Medical | Best Paper Award

Published on by Academic Achievements

Dr. Martin NICOL | Medical | Best Paper Award

Doctor at Cardiology department, Lariboisiere Saint Louis University of Paris, France

Dr. Martin Nicol is a distinguished French cardiologist with a specialization in cardio-oncology, cardiac imaging, and cardiovascular diseases. With over a decade of experience in both clinical and academic roles, he has made significant contributions to cardiology through his research, teaching, and clinical expertise. His work has garnered recognition at international conferences, and he continues to lead in the development of specialized cardiac care.

Profile:

SCOPUS

Education:

Dr. Nicol’s educational journey is rooted in some of France’s most prestigious institutions. He completed his medical degree from Université Paris 7 in 2018, where he also earned a Doctorate in Medicine. His postdoctoral training includes a DES in cardiology and vascular diseases from Université Paris 6. Dr. Nicol further specialized by obtaining several diplomas, including a DIU in cardio-oncology and echocardiography. His extensive academic background provided a solid foundation for his later research and clinical endeavors.

Experience:

Dr. Nicol’s professional experience spans across leading hospitals in Paris, where he served as an intern and later as a fellow in multimodal cardiac imaging at the Centre Cardiologique du Nord. He gained valuable experience in echocardiography, MRI, and cardiac scanning. From 2019 to 2021, he was the Chief of Clinic in the cardiology department at Lariboisière Hospital, where he developed specialized consultations in cardio-oncology. In 2022, he transitioned to private practice, joining the Maison Médicale de Mareil Marly and Ambroise Paré Hospital. Dr. Nicol also continues his work at Saint Louis Hospital, specializing in the treatment of amyloidosis.

Research Interest:

Dr. Nicol’s research is deeply centered on cardiovascular diseases, specifically focusing on cardiac amyloidosis, cardio-oncology, and cardiac imaging. His doctoral thesis on myocardial stiffness in heart failure highlighted his commitment to advancing diagnostic and treatment methods for complex cardiovascular conditions. He has collaborated with international research groups to further explore these areas, particularly in the integration of imaging modalities and their prognostic values.

Awards:

Dr. Nicol has received numerous accolades for his contributions to cardiology research. Notable among these is the Young Investigator Award at the Global Cardio-Oncology Summit in 2018 for his diagnostic score of cardiac involvement in AL amyloidosis. He also won several awards for his work on the cardiotoxicity induced by doxorubicin and trastuzumab, including the Best Oral Communication Award at GRRC 2018 and Best Poster Award at JFIC 2018.

Publications:

Dr. Nicol has published extensively in reputable cardiology journals. His work spans topics from subclinical left ventricular dysfunction during chemotherapy to the prognosis of cardiac amyloidosis. Some of his key publications include:

Nicol M, Deblaise J, Choussat R, Dubourg O, Mansencal N. “Side effects of ticagrelor: sinus node dysfunction with ventricular pause.” Int J Cardiol, 2015. Cited by 56 articles.

Nicol M, Baudet M, Cohen Solal A. “Subclinical left ventricular dysfunction during chemotherapy.” Card Fail Rev, 2019. Cited by 45 articles.

Nicol M, Cescau A, Baudet M, Harel S, Royer B. “Prognostic value of 123-I MIBG in AL amyloidosis.” Circ Cardiovasc Imaging, 2019. Cited by 38 articles.

Nicol M, Deney A, Lairez O, Vergaro G, Emdin M. “Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis.” Eur J Heart Fail, 2021. Cited by 29 articles.

Nicol M, Sadoune M, Azibani F. “Doxorubicin and trastuzumab induced cardiotoxicity in mice is not prevented by metoprolol.” ESC Heart Fail, 2021. Cited by 22 articles.

Nicol M, Siguret V, Vergaro G. “Thrombo-embolism and bleeding in patients with amyloidosis: A review.” ESC Heart Fail, 2022. Cited by 16 articles.

Nicol M, Hubert A, Coisne A. “Reproducibility of the 2016 American Society of Echocardiography-Algorithm for Estimation of Left Ventricular Filling Pattern.” Ultrasound Med Biol, 2022. Cited by 12 articles.

Nicol M, Vergaro G, Damy T. “Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis.” Front Cardiovasc Med, 2023. Cited by 10 articles.

Conclusion

Dr. Martin Nicol’s research contributions, particularly in the field of cardio-oncology and cardiac amyloidosis, make him a strong candidate for the Best Research Paper Award. His impressive record of publications, awards, and innovative research in multimodal cardiac imaging align well with the award’s criteria. Expanding his clinical trial work and focusing on mentorship could further enhance his qualifications, but his current profile already demonstrates a remarkable level of expertise and impact.

Alicja Sękowska | Clinical Microbiology and Infectious Diseases | Best Researcher Award

Published on by Academic Achievements

Assist Prof Dr.Alicja Sękowska | Clinical Microbiology and Infectious Diseases | Best Researcher Award

Lecturer Nicolaus Cpernicus University Ludwik Rydygier Collegium Medicum  Poland

Alicja Sękowska is an esteemed assistant professor in the Microbiology Department at Ludwik Rydygier Collegium Medicum in Bydgoszcz, part of Nicolaus Copernicus University in Torun. She also serves at the Microbiology Laboratory of University Hospital No. 1 of Dr. Antoni Jurasz in Bydgoszcz. Her expertise spans clinical, serological, and molecular microbiology, significantly contributing to medical microbiology.

Profile

Google Scholar

Education

🎓 Alicja Sękowska earned her Master’s degree in Biology from Nicolaus Copernicus University in Torun in 1998. She then pursued her Ph.D. in Microbiology, which she completed in 2006 at Ludwik Rydygier Collegium Medicum in Bydgoszcz, affiliated with Nicolaus Copernicus University in Torun.

Experience

🧪 Alicja has specialized in medical microbiology, achieving her first degree in 2002 and her second degree in 2011. She is a member of both the Polish Society of Microbiologists and the National Chamber of Laboratory Diagnosticians. Her leadership roles include serving as Chairwoman of the Bydgoszcz Department of the Polish Society of Microbiologists from 2012 to 2022 and as Vice Chairwoman since 2022. Additionally, she is a member of the National Examination Board in the field of medical microbiology.

Research Interests

🔬 Alicja’s research interests focus on clinical microbiology, serology, and molecular microbiology. Her work is vital in understanding and combating various microbial diseases, enhancing diagnostic techniques, and advancing medical microbiology practices.

Awards

🏆 Alicja’s dedication to microbiology has earned her recognition within the academic and scientific communities. Her awards highlight her contributions to the field, though specific awards are not listed here.

Publications

📚 Alicja Sękowska has an extensive publication record with a total of 65 articles, being the first author in 43 of them. She has also contributed to 4 chapters in two books. Here are some of her notable publications:

  1. “Article Title 1” – Published in Journal Name in Year, cited by X articles.
  2. “Article Title 2” – Published in Journal Name in Year, cited by X articles.
  3. “Article Title 3” – Published in Journal Name in Year, cited by X articles.